KDA Group Inc
XTSX:KDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Deutsche Konsum REIT-AG
XETRA:DKG
|
DE |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (29.4), the stock would be worth CA$-0.95 (924% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -3.6 | CA$0.12 |
0%
|
| Industry Average | 29.4 | CA$-0.95 |
-924%
|
| Country Average | 14.5 | CA$-0.47 |
-505%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
|
KDA Group Inc
XTSX:KDA
|
27m CAD | -3.6 | -3.5 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
98.3B USD | 14.1 | 55.6 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.3B EUR | 9.9 | 13.4 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.9B USD | 0 | 12.2 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.4B EUR | 14.3 | 19.2 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.2B EUR | 16.9 | 23.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.5B USD | 17.8 | 25.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.6B USD | 16.5 | 22.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.1B EUR | 9.9 | 11.2 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.8B USD | -28.2 | -28.4 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 9.7 | 13.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10.6 |
| Median | 14.5 |
| 70th Percentile | 20.6 |
| Max | 3 794.4 |
Other Multiples
KDA Group Inc
Glance View
KDA Group, Inc. engages in the provision of solutions and services to pharmaceutical market. The company is headquartered in Thetford Mines, Quebec. The company went IPO on 2009-09-09. The firm operates in three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. The Pharmacy Services segment provides pharmacy staff and placement and consulting services and training. The Pharmaceutical Solutions provides medical communication, technology solutions and health communication. The Technology segment offers software applications, including Virtual Clinics, Virtual Pharmacy, eCommerce for orders of medical cannabis products and Counselling and training Services on medical cannabis products for doctors, pharmacists and patients. Its subsidiaries include Alliance Pharma Operations inc., Elitis Pharma inc., Logistik Pharma inc., CanNorth Medic inc., Groupe Technologique KDA inc., CanNorth Medic International inc. and Pharmapar inc.
